These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 9592386)

  • 1. Ferrying proteins to the other side.
    Fernandez T; Bayley H
    Nat Biotechnol; 1998 May; 16(5):418-20. PubMed ID: 9592386
    [No Abstract]   [Full Text] [Related]  

  • 2. VP22-mediated intercellular transport correlates with enhanced biological activity of MybEngrailed but not (HSV-I) thymidine kinase fusion proteins in primary vascular cells following non-viral transfection.
    Sheridan PJ; Lawrie A; Crossman DC; Holt CM; Newman CM
    J Gene Med; 2005 Mar; 7(3):375-85. PubMed ID: 15543525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnology for drug and gene therapy: the importance of understanding molecular mechanisms of delivery.
    Labhasetwar V
    Curr Opin Biotechnol; 2005 Dec; 16(6):674-80. PubMed ID: 16263259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression of human mammary adenocarcinoma by systemic administration of a recombinant gene encoding the hFlex-TRAIL fusion protein.
    Wu X; He Y; Falo LD; Hui KM; Huang L
    Mol Ther; 2001 Mar; 3(3):368-74. PubMed ID: 11273779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant fusion proteins TAT-Mu, Mu and Mu-Mu mediate efficient non-viral gene delivery.
    Rajagopalan R; Xavier J; Rangaraj N; Rao NM; Gopal V
    J Gene Med; 2007 Apr; 9(4):275-86. PubMed ID: 17397090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential of oligonucleotides for therapeutic applications.
    Fichou Y; Férec C
    Trends Biotechnol; 2006 Dec; 24(12):563-70. PubMed ID: 17045686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyethylenimine-mediated in vivo gene transfer of a transmembrane superantigen fusion construct inhibits B16 murine melanoma growth.
    Jeudy G; Salvadori F; Chauffert B; Solary E; Vabres P; Chluba J
    Cancer Gene Ther; 2008 Nov; 15(11):742-9. PubMed ID: 18617917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercellular trafficking of VP22-GFP fusion proteins.
    Elliott G; O'Hare P
    Gene Ther; 1999 Jan; 6(1):149-51. PubMed ID: 10341888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein therapy-delivery guaranteed.
    Bayley H
    Nat Biotechnol; 1999 Nov; 17(11):1066-7. PubMed ID: 10545909
    [No Abstract]   [Full Text] [Related]  

  • 10. HVJ envelope vector, a versatile delivery system: its development, application, and perspectives.
    Zhang Q; Li Y; Shi Y; Zhang Y
    Biochem Biophys Res Commun; 2008 Aug; 373(3):345-9. PubMed ID: 18588856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug delivery of oligonucleotides by peptides.
    Lochmann D; Jauk E; Zimmer A
    Eur J Pharm Biopharm; 2004 Sep; 58(2):237-51. PubMed ID: 15296952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-penetrating peptides as vectors for peptide, protein and oligonucleotide delivery.
    Mäe M; Langel U
    Curr Opin Pharmacol; 2006 Oct; 6(5):509-14. PubMed ID: 16860608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective gene transfer to tumor cells by recombinant Newcastle Disease Virus via a bispecific fusion protein.
    Bian H; Fournier P; Moormann R; Peeters B; Schirrmacher V
    Int J Oncol; 2005 Feb; 26(2):431-9. PubMed ID: 15645128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene therapy progress and prospects: synthetic polymer-based systems.
    Schaffert D; Wagner E
    Gene Ther; 2008 Aug; 15(16):1131-8. PubMed ID: 18528432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herpes simplex virus VP22-human papillomavirus E2 fusion proteins produced in mammalian or bacterial cells enter mammalian cells and induce apoptotic cell death.
    Roeder GE; Parish JL; Stern PL; Gaston K
    Biotechnol Appl Biochem; 2004 Oct; 40(Pt 2):157-65. PubMed ID: 14709162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted delivery to the nucleus.
    Pouton CW; Wagstaff KM; Roth DM; Moseley GW; Jans DA
    Adv Drug Deliv Rev; 2007 Aug; 59(8):698-717. PubMed ID: 17681634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane-active peptides for non-viral gene therapy: making the safest easier.
    Ferrer-Miralles N; Vázquez E; Villaverde A
    Trends Biotechnol; 2008 May; 26(5):267-75. PubMed ID: 18358551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligonucleotide delivery: a cellular prospective.
    Liang E; Ajmani PS; Hughes JA
    Pharmazie; 1999 Aug; 54(8):559-66. PubMed ID: 10483609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biology and application of alphaviruses in gene therapy.
    Lundstrom K
    Gene Ther; 2005 Oct; 12 Suppl 1():S92-7. PubMed ID: 16231060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydrodynamic delivery.
    Al-Dosari MS; Knapp JE; Liu D
    Adv Genet; 2005; 54():65-82. PubMed ID: 16096008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.